Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009592
Filing Date
2023-05-12
Accepted
2023-05-12 16:01:35
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 1497315
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 16495
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 13460
4 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 7660
5 EX-32.2 tmb-20230331xex32d2.htm EX-32.2 6973
  Complete submission text file 0001558370-23-009592.txt   5704056

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230331.xsd EX-101.SCH 43731
7 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 42010
8 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 211934
9 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 297753
10 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 312782
60 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 819071
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 23915440
SIC: 2834 Pharmaceutical Preparations